The trademark SUVOGIC was filed by Principia Biopharma Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 9, 2021, and received one opposition filed on December 8, 2021 by Novartis AG on Likelihood of confusion. the opponent was represented by Abel & Imray LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 8, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 1, 2022. Change of name and address of the trademark registration was recorded on April 12, 2022.
The Opposition with reference B 003159923 was rejected according to Article 8(1)(b) EUTMR with decision issued on March 2, 2023 by the EUIPO.